Mercy Medical Center in Baltimore is the first in the mid-Atlantic to use Stryker's Blueprint Mixed Reality for shoulder surgeries, improving precision and customization for patient-specific orthopedic procedures.

MIT researchers advocate for a national bottle deposit program to boost the recycling rate of PET bottles from 24% to 82%.

CIDRAP at the University of Minnesota released an R&D roadmap to develop medical tools against the Nipah virus, emphasizing diagnostics, therapies, and vaccines.

Harvard specialists debate adjusting the age for colorectal cancer screenings due to rising early onset rates, balancing the potential benefits against costs and resource allocation.

A new geophysical technique developed at The University of Texas visualizes Earth's interior by using surface deformation, measuring the rigidity of the crust and mantle.

CIDRAP has released an updated roadmap to combat Lassa fever, focusing on development of vaccines, treatments, and diagnostics by the end of the decade.

Researchers have developed an implantable microphone for cochlear implants, potentially eliminating the need for external components and simplifying surgery and recovery.

Hillsborough County is implementing NGCS technology to improve its 911 system's reliability, ensuring effective emergency responses even during disasters.

A study reveals that 55% of water in U.S. rivers comes from ephemeral streams, which are not protected by the Clean Water Act, posing risks to waterways like the Connecticut River.

MIT and Brigham and Women’s Hospital have created a surgical method that enhances natural walking for individuals with limb amputations by improving neural feedback from residual limbs.

Texas expands offshore areas for carbon capture initiative, amidst debates on costs, technicalities, and the impact on fossil fuel reliance, as reported by the Texas Tribune.

The Wyndham Orlando Resort & Conference Center introduced an AI bartender named Sara, developed by Cecelia.ai, capable of making tequila-based drinks and engaging with guests.

MIT's Michael Birnbaum researches T cells and antigens to advance T cell therapies for conditions like cancer, creating tools to analyze their interactions.